The current financial score of Ionis Pharmaceuticals Inc is 7.68, ranking 93 out of 389 in the Biotechnology & Medical Research industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 246.09M, representing a year-over-year increase of 86.98%, while its net profit experienced a year-over-year increase of 37.03%.
Financials
4.01
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
6.86
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.54
Free cash flow
Relevant data have not been disclosed by the company yet.